Tennessee passes regenerative medicine bill backed by FPC

By AI, Created 10:23 AM UTC, May 20, 2026, /AGP/ – Tennessee lawmakers unanimously approved HB 2246, a new framework for regenerative and stem cell therapies that is set to take effect July 1, 2026, if Governor Bill Lee signs it. The bill could make Tennessee a national test case for physician-led innovation while tightening patient protections and sourcing rules.

Why it matters: - Tennessee’s HB 2246 could expand access to regenerative therapies while setting stricter guardrails on sourcing, consent and advertising. - The law may also give physicians clearer room to offer treatments within their scope of practice. - Supporters say the framework could help position Memphis and Tennessee as a hub for responsible regenerative medicine.

What happened: - The Tennessee General Assembly passed HB 2246 unanimously. - The Financial Policy Council applauded the measure on May 1, 2026. - Governor Bill Lee is expected to sign the bill. - The law is scheduled to take effect July 1, 2026. - The legislation builds on similar efforts in Utah, Alabama and Florida.

The details: - HB 2246 authorizes physicians to provide regenerative therapies within their scope of practice. - The law requires ethical sourcing from FDA-registered or accredited facilities. - The measure prohibits fetal or embryo-derived cells. - The bill includes clear carve-outs for autologous therapies. - The law requires informed consent and transparent advertising disclosures. - The legislation encourages participation in outcomes registries. - The Financial Policy Council said the framework protects patients while empowering responsible physician innovation. - In Germantown, sYlf™ Regenerative Medicine has spent nearly a decade promoting autologous cellular medicine, according to the practice. - Dr. Gregory Laurence said the practice’s approach centers on baseline assessment, restrained deployment, measurement and refinement. - sYlf™ Regenerative Medicine developed sYlfTracker™, a private, patient-controlled tool for documenting what technology was delivered and tracking outcomes at 30 days and 12 months. - The tool also tracks satisfaction relative to cost and recovery. - In Memphis, sYlf™ Regenerative Medicine works with Dr. David Buechner, a board-certified interventional neuroradiologist with more than 30 years of experience, for image-guided administration of regenerative technologies.

Between the lines: - The bill reflects a broader push to distinguish regulated regenerative medicine from loosely defined stem cell marketing. - The emphasis on consent, sourcing and registries suggests lawmakers are trying to balance innovation with patient protection. - Memphis is being framed as an early proving ground for physician-led regenerative care, especially as local practices and specialists align around the new rules.

What’s next: - Governor Lee’s signature would put the new framework into force on July 1, 2026. - Tennessee physicians could begin operating under the law’s new standards once it takes effect. - The Financial Policy Council said it will continue participating in policy discussions around access, safety and ethics. - sYlf™ Regenerative Medicine says it will continue advancing physician education and public understanding of regenerative therapies.

The bottom line: - Tennessee is poised to become one of the clearest state-level experiments in how to regulate regenerative medicine without blocking physician innovation. - If the law works as intended, Memphis could emerge as a visible center for the field.